<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04853940</url>
  </required_header>
  <id_info>
    <org_study_id>419/20</org_study_id>
    <nct_id>NCT04853940</nct_id>
  </id_info>
  <brief_title>Respiratory Muscle Function, Dyspnea, Exercise Capacity and Quality of Life in Severe COVID19 Patients</brief_title>
  <official_title>Respiratory Muscle Function, Dyspnea, Exercise Capacity and Quality of Life in Severe COVID19 Patients After ICU Discharge: a 6 Months Follow-up Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal</source>
  <brief_summary>
    <textblock>
      Further knowledge regarding sequelae in severe COVID-19 patients who have required ICU&#xD;
      admission for invasive mechanical ventilation is still needed. Available evidence suggests&#xD;
      ongoing respiratory impairment and impact in quality of life.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PURPOSE: To evaluate post-ICU clinical outcomes in severe COVID-19 ICU survivors.&#xD;
&#xD;
      DESIGN: A prospective observational study conducted in public hospital in Madrid, Spain.&#xD;
&#xD;
      METHODS:&#xD;
&#xD;
      Participants: patients diagnosed with severe COVID-19 who have survived ICU admission for&#xD;
      invasive mechanical ventilation and have been discharged from hospital.&#xD;
&#xD;
      Intervention: Patients will be invited to attend follow-up visits at the hospital for&#xD;
      assessments 3 months and 6 months after ICU discharge.&#xD;
&#xD;
      Outcome measures: Tests of respiratory muscles function will include ultrasonography of the&#xD;
      diaphragm muscle to measure diaphragm thickness (DT), diaphragm thickening ratio (TR) and&#xD;
      diaphragm excursion (DE); respiratory muscle strength measurement to obtain Maximal&#xD;
      Inspiratory Pressure (MIP), Maximal Expiratory Pressure (MEP) and Maximal Sniff Nasal&#xD;
      Inspiratory Pressure (SNIP); functional exercise capacity will be assessed with the Six&#xD;
      Minutes Walk Test (6MWT); dyspnea and health-related quality of life will be evaluated with&#xD;
      the Modified Medical Research Council Scale (mMRC Scale) and the Saint George's Respiratory&#xD;
      Questionnaire (SGRQ). Data on participants' demographics and clinical data will also be&#xD;
      collected.&#xD;
&#xD;
      Statistical Analysis: Descriptive statistics will be used to summarise data. Spearman's&#xD;
      correlation coefficients will be used to explore associations between variables.&#xD;
&#xD;
      CONCLUSIONS AND SIGNIFICANCE OF THE RESEARCH: Understanding post-ICU clinical outcomes in&#xD;
      patients with severe COVID-19 may help develop future prevention, therapeutic and follow-up&#xD;
      strategies that improve quality of care and outcomes&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Maximal Inspiratory Pressure (MIP) (centimetres of water, cmH20)</measure>
    <time_frame>&lt; 3 months after ICU discharge</time_frame>
    <description>It is the greater pressure which may be generated during maximal inspiration by the inspiratory muscles.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Maximal Inspiratory Pressure (MIP) (centimetres of water, cmH20)</measure>
    <time_frame>&lt; 6 months after ICU discharge</time_frame>
    <description>It is the greater pressure which may be generated during maximal inspiration by the inspiratory muscles.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diaphragm Thickening Ratio during deep breathing (centimetres)</measure>
    <time_frame>&lt; 3 months after ICU discharge</time_frame>
    <description>B-mode Diaphragm ultrasound will be performed to measure diaphragm thickening ratio during deep breathing. Diaphragm Thickening Ratio = Diaphragm Thickness at Functional Residual Capacity/ Diaphragm thickness at Total Lung Capacity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diaphragm Thickening Ratio during deep breathing (centimetres)</measure>
    <time_frame>&lt; 6 months after ICU discharge</time_frame>
    <description>B-mode Diaphragm ultrasound will be performed to measure diaphragm thickening ratio during deep breathing. Diaphragm Thickening Ratio = Diaphragm Thickness at Functional Residual Capacity/ Diaphragm thickness at Total Lung Capacity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diaphragm Thickening Ratio during quiet breathing (centimetres)</measure>
    <time_frame>&lt; 3 months after ICU discharge</time_frame>
    <description>B-mode Diaphragm ultrasound will be performed to measure diaphragm thickening ratio at Tidal Volume. Diaphragm Thickening Ratio = Diaphragm Thickness at the end of a quiet expiration/ Diaphragm thickness at the end of a quiet inspiration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diaphragm Thickening Ratio during quiet breathing (centimetres)</measure>
    <time_frame>&lt; 6 months after ICU discharge</time_frame>
    <description>B-mode Diaphragm ultrasound will be performed to measure diaphragm thickening ratio at Tidal Volume. Diaphragm Thickening Ratio = Diaphragm Thickness at the end of a quiet expiration/ Diaphragm thickness at the end of a quiet inspiration.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diaphragm Excursion during deep breathing (centimetres)</measure>
    <time_frame>&lt; 3 months after ICU discharge</time_frame>
    <description>M-mode Diaphragm Ultrasound imaging will be performed to measure diaphragm excursion during deep breathing defined as the displacement (centimetres) of the diaphragm between Functional Residual Capacity and Total Lung Capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diaphragm Excursion during deep breathing (centimetres)</measure>
    <time_frame>&lt; 6 months after ICU discharge</time_frame>
    <description>M-mode Diaphragm Ultrasound imaging will be performed to measure diaphragm excursion during deep breathing defined as the displacement (centimetres) of the diaphragm between Functional Residual Capacity and Total Lung Capacity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Expiratory Pressure (MEP) (cmH20)</measure>
    <time_frame>&lt; 3 months after ICU discharge</time_frame>
    <description>It is the greater pressure which may be generated during maximal expiration by the inspiratory muscles.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximal Expiratory Pressure (MEP) (cmH20)</measure>
    <time_frame>&lt; 6 months after ICU discharge</time_frame>
    <description>It is the greater pressure which may be generated during maximal expiration by the inspiratory muscles.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Medical Research Council (mMRC) Dyspnea score</measure>
    <time_frame>&lt; 3 months following ICU discharge</time_frame>
    <description>Dyspnea will be measured with the mMRC Dyspnea scale (range: 0-4, higher values indicating higher level of dyspnea)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Modified Medical Research Council (mMRC) Dyspnea score</measure>
    <time_frame>&lt; 6 months following ICU discharge</time_frame>
    <description>Dyspnea will be measured with the mMRC Dyspnea scale (range: 0-4, higher values indicating higher level of dyspnea)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-Minutes Walk Test (6MWT) (metres)</measure>
    <time_frame>&lt; 3 months following ICU discharge</time_frame>
    <description>The 6MWT will be used to measure exercise capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6-Minutes Walk Test (6MWT) (metres)</measure>
    <time_frame>&lt; 6 months following ICU discharge</time_frame>
    <description>The 6MWT will be used to measure exercise capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Saint George's Respiratory Questionnaire (SGRQ) score</measure>
    <time_frame>&lt; 3 months following ICU dischargemonths following ICU discharge</time_frame>
    <description>The SGRQ is used to measure health-related quality of life (range: 0-100, higher scores represent higher impairment in quality of life)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Saint George's Respiratory Questionnaire (SGRQ) score</measure>
    <time_frame>&lt; 6 months following ICU dischargemonths following ICU discharge</time_frame>
    <description>The SGRQ is used to measure health-related quality of life (range: 0-100, higher scores represent higher impairment in quality of life)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Covid19</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data collection and clinical testing of subjects</intervention_name>
    <description>6-months follow-up with clinical testing at 3 and 6 months</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with COVID19 pneumonia who are discharged from the Ramón y Cajal&#xD;
        University Hospital ICU from 1 October 2020 to 28 February 2021 will be eligible for the&#xD;
        study&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ⋧18 years old,&#xD;
&#xD;
          -  subjects diagnosed with COVID-19 confirmed by positive SARS-CoV-2 PCR testing who&#xD;
             require admission to ICU for invasive mechanical ventilation&#xD;
&#xD;
          -  invasive ventilation &gt; 24 hours.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pre-existing cognitive impairment,&#xD;
&#xD;
          -  communication/language barrier&#xD;
&#xD;
          -  any concurrent physical or mental health condition/ impairment that prevents subjects&#xD;
             from taking part in evaluations or providing informed consent&#xD;
&#xD;
          -  loss of independent walking ability (with or without walking aids) prior to&#xD;
             hospitalisation defined by a score of ≤2 on the mobility item of the modified Barthel&#xD;
             Index,&#xD;
&#xD;
          -  pregnancy,&#xD;
&#xD;
          -  any injuries/surgery that requires medical bed rest.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luís López-González, PT, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Maria-Natividad Seisdedos-Nuñez, BSc,MSc</last_name>
    <phone>0034913368000</phone>
    <phone_ext>8250</phone_ext>
    <email>marianatividad.seisdedos@salud.madrid.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>ICU. Ramón y Cajal University Hospital</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria-Natividad Seisdedos-Núñez, PT, MSc</last_name>
      <phone>0034913368000</phone>
      <phone_ext>8250</phone_ext>
      <email>marianatividad.seisdedos@salud.madrid.org</email>
    </contact>
    <contact_backup>
      <last_name>Luís López-González, PT,MSc</last_name>
      <phone>0034913368000</phone>
      <phone_ext>8250</phone_ext>
      <email>luislopezgonzalez4@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Irene Lázaro Navas, BSc, MSc, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Valcarcel Linares, BSc, MScc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Teresa Gómez González, Bec,</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>April 12, 2021</study_first_submitted>
  <study_first_submitted_qc>April 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 22, 2021</study_first_posted>
  <last_update_submitted>May 1, 2021</last_update_submitted>
  <last_update_submitted_qc>May 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal</investigator_affiliation>
    <investigator_full_name>Maria Natividad Seisdedos Nunez</investigator_full_name>
    <investigator_title>Senior Physiotherapist, MSc</investigator_title>
  </responsible_party>
  <keyword>COVID19</keyword>
  <keyword>Diaphragm ultrasound</keyword>
  <keyword>Respiratory muscle strength</keyword>
  <keyword>Dyspnea</keyword>
  <keyword>Exercise Capacity</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Post-ICU outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Dyspnea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

